Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Reichardt

Showing results (1-10 of 193) with videos related to

Pageof 20
Sort By:
Oncology|April 15, 2010
Optimal use of targeted agents for advanced gastrointestinal stromal tumoursPeter Reichardt
Future Oncology (London, England)|June 10, 2021
Uncertainties that threaten the benefit/risk balance in early treatment lines for advanced or metastatic soft tissue sarcomaPeter Reichardt
Future Oncology (London, England)|September 11, 2019
ForewordPeter Reichardt
Future Oncology (London, England)|June 5, 2015
Beyond clinical trials in advanced soft tissue sarcoma: what to expect from trabectedin treatment? ForewordPeter Reichardt
Oncology Research and Treatment|June 13, 2018
The Story of Imatinib in GIST - a Journey through the Development of a Targeted TherapyPeter Reichardt
Critical Reviews in Oncology/Hematology|February 22, 2002
High-dose chemotherapy in adult soft tissue sarcomaPeter Reichardt
Expert Review of Anticancer Therapy|May 4, 2013
Current questions in soft tissue sarcoma: further steps with Yondelis®Peter Reichardt
Future Oncology (London, England)|July 23, 2014
Soft tissue sarcomas, a look into the future: different treatments for different subtypesPeter Reichardt
Current Oncology Reports|September 10, 2008
Novel approaches to imatinib- and sunitinib-resistant GISTPeter Reichardt
Deutsche Medizinische Wochenschrift (1946)|January 29, 2021
[Treatment of soft tissue sarcomas including GIST - Update 2021]Peter Reichardt, Daniel Pink
Pageof 20

Showing results (1-10 of 193) with videos related to

Sort By:
Pageof 20
Oncology|April 15, 2010
Optimal use of targeted agents for advanced gastrointestinal stromal tumoursPeter Reichardt
Future Oncology (London, England)|June 10, 2021
Uncertainties that threaten the benefit/risk balance in early treatment lines for advanced or metastatic soft tissue sarcomaPeter Reichardt
Future Oncology (London, England)|September 11, 2019
ForewordPeter Reichardt
Future Oncology (London, England)|June 5, 2015
Beyond clinical trials in advanced soft tissue sarcoma: what to expect from trabectedin treatment? ForewordPeter Reichardt
Oncology Research and Treatment|June 13, 2018
The Story of Imatinib in GIST - a Journey through the Development of a Targeted TherapyPeter Reichardt
Critical Reviews in Oncology/Hematology|February 22, 2002
High-dose chemotherapy in adult soft tissue sarcomaPeter Reichardt
Expert Review of Anticancer Therapy|May 4, 2013
Current questions in soft tissue sarcoma: further steps with Yondelis®Peter Reichardt
Future Oncology (London, England)|July 23, 2014
Soft tissue sarcomas, a look into the future: different treatments for different subtypesPeter Reichardt
Current Oncology Reports|September 10, 2008
Novel approaches to imatinib- and sunitinib-resistant GISTPeter Reichardt
Deutsche Medizinische Wochenschrift (1946)|January 29, 2021
[Treatment of soft tissue sarcomas including GIST - Update 2021]Peter Reichardt, Daniel Pink
Pageof 20